This webinar will discuss a set of in vitro assays that tackle the challenges of in vitro hepatotoxicity assessment.

The European Medicines Agency issued guidelines to help minimize the risk of a rare but serious liver injury associated with Hungarian drugmaker Richter’s Esmya.

The prescribing label for Biogen’s big-selling oral multiple sclerosis drug Tecfidera has been updated to include a warning of potential liver injury.